Foretinib (XL880): c-MET inhibitor with activity in papillary renal cell cancer.

Foretinib (XL880): c-MET inhibitor with activity in papillary renal cell cancer.

Item
http://www.wikidata.org/entity/Q38081379
Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancerRealizing the promise of cancer predisposition genes.Foretinib Enhances the Radiosensitivity in Esophageal Squamous Cell Carcinoma by Inhibiting Phosphorylation of c-MetA rapid and sensitive LC-MS/MS method for evaluation of the absolute oral bioavailability of a novel c-Met tyrosine kinase inhibitor QBH-196 in rats.Systematic screen with kinases inhibitors reveals kinases play distinct roles in growth of osteoprogenitor cellsTropomyosin receptor kinase inhibitors: a patent update 2009 - 2013.The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme.Dasatinib Modulates Invasive and Migratory Properties of Canine Osteosarcoma and has Therapeutic Potential in Affected Dogs
P2860

Foretinib (XL880): c-MET inhibitor with activity in papillary renal cell cancer.

Item
http://www.wikidata.org/entity/Q38081379
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Foretinib (XL880): c-MET inhibitor with activity in papillary renal cell cancer.
@en
type
label
Foretinib (XL880): c-MET inhibitor with activity in papillary renal cell cancer.
@en
prefLabel
Foretinib (XL880): c-MET inhibitor with activity in papillary renal cell cancer.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
Foretinib (XL880): c-MET inhibitor with activity in papillary renal cell cancer.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698